Introduction
Candidiasis, usually caused by Candida albicans but also by other Candida spp. is the most common of the opportunistic fungal infections (1) . Prevalence is particularly high in a hospital environment (nosocomial infection) (2) and in individuals with immune deficiencies such as human immunodeficiency virus-infected patients and bone marrow transplant recipients (3, 4) . A variety of antifungal agents (fluconazole and related azoles, amphotericin B) are available for treatment of Candida spp. infections but resistance to these drugs is rapidly increasing (5, 6) . Consequently, there is a clear need to develop new types of antifungal agents to which the pathogens have not been exposed in order to control infections caused by drugresistant strains.
The skins of frogs of the genus Rana have proved to be a rich source of peptides with broad spectrum antibacterial activity, some of which show antifungal properties [reviewed in (7, 8) ]. The peptides are synthesized as a complex array of structurally related components that may be grouped into families on the basis of structural similarity.
Among the North American ranid frogs, nine families of peptides have been identified: esculentin-1, esculentin-2, brevinin-1, ranatuerin-1, ranatuerin-2, temporin, palustrin-1, palustrin-2, and palustrin-3 [reviewed in (9) ].
Among ranid frogs of Eurasian origin, additional families include brevinin-2 (10), tigerinin (11) , japonicin-1 (12) and japonicin-2 (12) . It has been speculated that this molecular diversity is important in protecting the animals against invasion by a wide range of microbial species (13) .
The foothill yellow-legged frog Rana boylii is a relatively small (4-7 cm), strongly aquatic amphibian that inhabits streams in coastal and mountain areas of California and Oregon. Recent years have seen marked declines in population in several regions of their range that have been ascribed to disruptions of habitat, such as alteration of stream flows, pollution of the environment by wind-borne pesticides (14) , and displacement by invasions of the bullfrog, R. catesbeiana (15) . It is currently being petitioned that the species should be listed for Federal protection. The present study describes the isolation and characterization of six antimicrobial peptides from the skin secretions of R. boylii, one of which shows high potency against C. albicans.
Experimental

Collection of skin secretions
A single adult male specimen of R. boylii (body weight 18 g) was collected in Shasta County, Northern California under California Department of Fish and Game permit number 801023-05 issued to Carlos Davidson. The animal was transported to Vanderbilt University and housed in a polycarbonate vivarium containing wet and dry areas. The frog was fed live crickets three times weekly. All experimental procedures were approved by the Vanderbilt University Institutional Animal Care and Use Committtee. Skin secretions were collected at monthly intervals for 5 months as previously described (9) . In brief, the animal was injected and 280 nm and fractions (1 min) were collected. The fractions containing antimicrobial activity were rechroma-
The concentration of acetonitrile in the eluting solvent was raised from 35 to 63% over 40 min and the flow rate was 2 mL/min.
Structural characterization
The primary structures of the peptides were determined by automated Edman degradation using an Applied Biosystems 
Results
Purification of the peptides
The two pooled samples of concentrated secretions (samples A and B) were tested for their ability to inhibit growth of the fungus C. albicans, the Gram-negative bacterium E. coli and the Gram-positive bacterium S. aureus. Antimicrobial activities against the three microorganisms were detected in both crude extracts even at high sample dilution. Samples A and B were separately chromatographed on a semi-preparative Vydac C-18 column. The elution profiles, shown in Fig. 1A and B, are remarkably similar particularly in the region of the chromatogram associated with antimicrobial activity (retention times between 47 and 66 min). Five prominent, well resolved peaks, subsequently shown to contain ranatuerin-2BYa (peak 1), brevinin-1BYa (peak 3), brevinin-1BYb (peak 4), temporin-1BYa (peak 5), and brevinin-1BYc (peak 6) were associated with growthinhibitory activity towards S. aureus. Peaks 3, 4, and 6
inhibited growth of C. albicans. Peak 2 (Fig. 1) contained a peptide, subsequently shown to be ranatuerin-2Byb, that inhibited the growth of E. coli only. The peptides were purified to near homogeneity, as assessed by a symmetrical peak shape, by further chromatography on a semipreparative Vydac C-4 column. Purification of brevinin-1BYa is shown in Fig. 2 . The final yields (nmol) of the pure peptides, (Fig. 3) .
Antimicrobial and hemolytic properties
The abilities of the peptides isolated in this study to inhibit the growth of C. albicans, E. coli and S. aureus and to produce hemolysis of human erythrocytes are compared in Table 1 . membrane-mimetic environment (26) . As shown in Table 1 , the substitution (Phe 12 fi Leu) in brevinin-1BYa results in a fourfold reduction in potency against C. albicans and a twofold reduction against the gram-positive bacterium S. aureus without significant change in potency against the Gram-negative bacterium E. coli or in hemolytic activity.
This selective reduction in potency may be ascribed to a decrease in hydrophobicity. In a series of analogs related to magainin 2, it was shown that increasing overall hydrophobicity and hydrophobic moment (27) had relatively little influence on activity against Gram-negative bacteria but enhanced activity against Gram-positive bacteria (28) . The appreciably lower potency of brevinin-1BYc against microorganisms, particularly E. coli, may be ascribed to the substitution Lys 11 fi Thr. The cationic residues in an antimicrobial peptide are considered to be important in the initial binding to the negatively charged phospholipids in the cell membranes of microorganisms (25) and, up to a certain limit, there is a good correlation between peptide cationicity and antimicrobial potency in a range of systems (29) .
Brevinin-1BYa is the most potent peptide against C. albicans to be isolated from frog skin by the present investigators which, taken together with its broad spectrum antibacterial activity, make it a candidate for drug development. However, its therapeutic potential is seriously limited by its strong hemolytic activity. A helical wheel representation of brevinin-1BYa indicates that the peptide has the propensity to form a strongly amphipathic a-helix.
Several studies have demonstrated a direct correlation between degree of amphipathicity and hemolytic activity, not only in peptides that form an a-helix (28, 30, 31) , but also those that adopt a b-sheet conformation (32) . It has been suggested that increasing the hydrophobic moment of an antimicrobial peptide has a relatively modest effect on the ability to permeabilize the negatively charged cell membrane of microorganisms but a marked effect on the more zwitterionic phospholipid membrane of the erythrocyte (30) . Further studies, therefore, will focus upon the synthesis of brevinin-1BYa analogs with increased cationicity but reduced amphipathicity.
Peptides of the ranatuerin-2 family were first isolated from extracts of the skin of the bullfrog, R. catesbeiana (18) but are widely distributed in ranid frogs of North American origin (9, 20, 21, 23) . Consistent with properties of ranatuerin-2BYa and ranatuerin-2BYb, the ranatuerins generally show low potencies against human pathogens including C. albicans but ranatuerin-2P, isolated from the skin of R. pipiens (20) , has been shown to be active against frog Temporin-1Lc ----LINLIHK---.NH 2 Figure 4 . A comparison of the primary structures of the brevinin-1 and ranatuerin-2 peptides isolated from Rana boylii and R. luteiventris. ()) denotes residue identity. Peptides designated -BY are from R. boylii and designated -L are from R. luteiventris. Gaps have been introduced into the sequences to maximize structural similarity.
